Polaryx Therapeutics has received from the US FDA both Rare Pediatric Disease and Orphan Drug designations for the treatment of GM2 gangliosidosis with PLX-300... Nov 25
ISD and Biogen will work together to develop ISD's lead compound, ISD 017, which is being developed to treat severe lupus - systemic lupus erythematosus (... Nov 24
NOV03 showed statistically significant improvement of certain symptoms, such as severity and frequency of dryness and burning/stinging of the eyes... Nov 24
The two partners want to pool their expertise in order to identify and develop new monoclonal antibodies for cancer therapy... Nov 24
Oxlumo received orphan drug designation, which provides incentives to assist and encourage drug development for rare diseases... Nov 24
The company has experienced an evolving increased presence of Telstar GMP freeze-dryers in China and currently let customers a complete support laboratory service... Nov 24
ARCA believes that AB201 is the only anticoagulant class new chemical entity in development for COVID-19 that has a Fast Track designation... Nov 24
These tests will be free of cost for the people. This initiative is a step in making COVID-19 testing affordable and more accessible to ... Nov 24
The amfAR Foundation for AIDS Research, to test the ability of Vyrologix (leronlimab) to mediate a functional HIV cure... Nov 24
Clinical trials are also being conducted in the US, Japan, Russia, South Africa, Kenya and Latin America with planned trials in other European and Asian ... Nov 24
-Advertisements-
Friday, June 14, 2024
